Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23755922)

  • 1. Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.
    Fraunholz I; Rödel F; Kohler D; Diallo-Georgiopoulou M; Distel L; Falk S; Rödel C
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):901-7. PubMed ID: 23755922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.
    Fraunholz I; Rödel C; Distel L; Rave-Fränk M; Kohler D; Falk S; Rödel F
    Radiat Oncol; 2012 Jun; 7():88. PubMed ID: 22697293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?
    Zilli T; Schick U; Ozsahin M; Gervaz P; Roth AD; Allal AS
    Radiother Oncol; 2012 Jan; 102(1):62-7. PubMed ID: 21993403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.
    Doll CM; Moughan J; Klimowicz A; Ho CK; Kornaga EN; Lees-Miller SP; Ajani JA; Crane CH; Kachnic LA; Okawara GS; Berk LB; Roof KS; Becker MJ; Grisell DL; Ellis RJ; Sperduto PW; Marsa GW; Guha C; Magliocco AM
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):554-562. PubMed ID: 28126304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-five-year experience with radical chemoradiation for anal cancer.
    Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation.
    Li S; Kim JS; Kim JM; Cho MJ; Yoon WH; Song KS; Yeo SG; Kim JS
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):705-12. PubMed ID: 16690221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
    Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
    Chakravarti A; Winter K; Wu CL; Kaufman D; Hammond E; Parliament M; Tester W; Hagan M; Grignon D; Heney N; Pollack A; Sandler H; Shipley W
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):309-17. PubMed ID: 15890569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy.
    Rödel F; Martin D; Helmke C; Balermpas P; Fokas E; Wieland U; Rave-Fränk M; Kitz J; Matthess Y; Raab M; Strebhardt K; Rödel C
    Oncotarget; 2016 Aug; 7(33):53339-53349. PubMed ID: 27462786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.
    Bentzen AG; Guren MG; Wanderås EH; Frykholm G; Tveit KM; Wilsgaard T; Dahl O; Balteskard L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e173-80. PubMed ID: 22436791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.
    Williams M; Swampillai A; Osborne M; Mawdsley S; Hughes R; Harrison M; Harvey R; Glynne-Jones R;
    Cancer; 2013 Jul; 119(13):2391-8. PubMed ID: 23576077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
    Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.
    Buchholz TA; Tu X; Ang KK; Esteva FJ; Kuerer HM; Pusztai L; Cristofanilli M; Singletary SE; Hortobagyi GN; Sahin AA
    Cancer; 2005 Aug; 104(4):676-81. PubMed ID: 15981280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor as a predictor of tumor response to preoperative chemoradiation in locally advanced gastric carcinoma.
    Sirak I; Petera J; Hatlova J; Vosmik M; Melichar B; Dvorak J; Zoul Z; Tycova V; Lesko M; Hajduch M
    Strahlenther Onkol; 2008 Nov; 184(11):592-7. PubMed ID: 19016018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of anal cancer patients at the Ottawa hospital.
    Abunassar M; Reinders J; Jonker DJ; Asmis T
    Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.